Medication safety in neonatal care: a review of medication errors among neonates

Natalia Krzyzaniak1, Beata Bajorek2

  • 1University of Technology, Sydney, Graduate School of Health (Pharmacy), PO Box 123, Broadway, NSW 2007, Australia.

Insights

Hospital medication errors are common across all ages, with neonates experiencing unique overdosing risks. Integrating clinical pharmacists can help mitigate these medication errors.

Area of Science:

  • Medical Safety
  • Pharmacology
  • Patient Care

Background:

  • Medication errors represent a significant patient safety concern in hospitalized individuals.
  • Understanding error patterns across different age groups, from neonates to the elderly, is crucial for targeted interventions.

Purpose of the Study:

  • To delineate medication errors in hospitalized patients.
  • To compare medication errors in neonates with those occurring across the entire age spectrum.

Main Methods:

  • A comprehensive literature search was conducted across PubMed, Embase, and Google Scholar.
  • Searches focused on identifying medication errors in pediatric, adult, elderly, and neonatal hospitalized populations.

Main Results:

  • Fifty-eight articles were reviewed, confirming medication errors in all patient groups.
  • Prescribing and administration errors, particularly dosing errors, were most frequent.
  • Neonates showed high rates of overdosing and misidentification errors; elderly patients had unique issues like therapy duplication.
  • Commonly implicated medications included heparin, antibiotics, insulin, morphine, and parenteral nutrition.

Conclusions:

  • All stages of medication use are vulnerable to errors across patient age groups.
  • Developing targeted strategies for specific populations, including integrating pharmacy services, is essential for improving medication safety.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...